zotarolimus

Known as: zotarilumus 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
IMPORTANCE The current recommendation is for at least 12 months of dual antiplatelet therapy after implantation of a drug-eluting… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES The goal of this study was to evaluate shorter duration (3 months) dual antiplatelet therapy (DAPT) after drug-eluting… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2012
Review
2012
BACKGROUND The relative safety of drug-eluting stents and bare-metal stents, especially with respect to stent thrombosis… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVES The ENDEAVOR IV (Randomized Comparison of Zotarolimus-Eluting and Paclitaxel-Eluting Stents in Patients with Coronary… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVES The aim of this study was to evaluate the relative efficacy and safety of zotarolimus-eluting stents (ZES) in… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVES The purpose of this study was to assess trends in endothelial coverage and recovery among leading polymer-based drug… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVES This trial examined the relative clinical efficacy, angiographic outcomes, and safety of zotarolimus-eluting coronary… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The use of the Endeavor stent might reduce restenosis and stent thrombosis at 9 months. METHODS AND RESULTS Patients… (More)
Is this relevant?